{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:20:43Z","timestamp":1790364043766,"version":"4.1.0"},"reference-count":45,"publisher":"Royal College of General Practitioners","issue":"736","license":[{"start":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T00:00:00Z","timestamp":1549929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Gen Pract"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Faecal immunochemical test (FIT) usage for symptomatic patients is increasing, but variations in use caused by sociodemographic factors are unknown. A clinical pathway for colorectal cancer (CRC) was introduced in primary care for symptomatic patients in November 2017. The pathway was commissioned to provide GPs with direct access to FITs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To identify whether sociodemographic factors affect FIT return in symptomatic patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design and setting<\/jats:title><jats:p>A retrospective study was undertaken in Nottingham, UK, following the introduction of FIT as triage tool in primary care. It was mandated for all colorectal referrals (except rectal bleeding or mass) to secondary care. FIT was used, alongside full blood count and ferritin, to stratify CRC risk.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>All referrals from November 2017 to December 2021 were retrospectively reviewed. Sociodemographic factors affecting FIT return were analysed by multivariate logistic regression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 35 289 (90.7%) patients returned their index FIT, while 3631 (9.3%) did not. On multivariate analysis, males were less likely to return an FIT (odds ratio [OR] 1.11, 95% confidence interval [CI] = 1.03 to 1.19). Patients aged \u226565 years were more likely to return an FIT (OR 0.78 for non-return, 95% CI = 0.72 to 0.83). Unreturned FIT more than doubled in the most compared with the least deprived quintile (OR 2.20, 95% CI = 1.99 to 2.43). Patients from Asian (OR 1.82, 95% CI = 1.58 to 2.10), Black (OR 1.21, 95% CI = 0.98 to 1.49), and mixed or other ethnic groups (OR 1.29, 95% CI = 1.05 to 1.59) were more likely to not return an FIT compared with patients from a White ethnic group. A total of 599 (1.5%) CRCs were detected; 561 in those who returned a first FIT request.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>FIT return in those suspected of having CRC varied by sex, age, ethnic group, and socioeconomic deprivation. Strategies to mitigate effects on FIT return and CRC detection should be considered as FIT usage expands.<\/jats:p><\/jats:sec>","DOI":"10.3399\/bjgp.2023.0033","type":"journal-article","created":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T15:20:47Z","timestamp":1692804047000},"page":"e843-e849","source":"Crossref","is-referenced-by-count":22,"title":["Sociodemographic variations in the uptake of faecal immunochemical tests in primary care: a retrospective study"],"prefix":"10.3399","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2437-3050","authenticated-orcid":false,"given":"James A","family":"Bailey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4885-5740","authenticated-orcid":false,"given":"Alastair J","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5529-2106","authenticated-orcid":false,"given":"James","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1188-2320","authenticated-orcid":false,"given":"Caroline J","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0772-2893","authenticated-orcid":false,"given":"Joanne R","family":"Morling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heetan","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3094-2870","authenticated-orcid":false,"given":"Ayan","family":"Banerjea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7071-4098","authenticated-orcid":false,"given":"David J","family":"Humes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1987","published-online":{"date-parts":[[2023,8,23]]},"reference":[{"key":"2023102617252850000_73.736.e843.1","unstructured":"Cancer Research UK Bowel cancer statistics. https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/bowel-cancer (accessed 27 Sep 2023)."},{"key":"2023102617252850000_73.736.e843.2","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v7.i12.422"},{"key":"2023102617252850000_73.736.e843.3","unstructured":"NHS Digital (2023) Cancer survival in England, cancers diagnosed 2016 to 2020, followed up to 2021. https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/cancer-survival-in-england\/cancers-diagnosed-2016-to-2020-followed-up-to-2021 (accessed 6 Oct 2023)."},{"issue":"1","key":"2023102617252850000_73.736.e843.4","first-page":"CD001216","article-title":"Screening for colorectal cancer using the faecal occult blood test, Hemoccult","volume":"2007","author":"Hewitson","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2023102617252850000_73.736.e843.5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.surge.2020.02.004","article-title":"Screen detection is a survival predictor independent of pathological grade in colorectal cancer. A prospective cohort study","volume":"19","author":"Chan","year":"2021","journal-title":"Surgeon"},{"key":"2023102617252850000_73.736.e843.6","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.canep.2016.06.003","article-title":"Increased survival and decreased recurrence in colorectal cancer patients diagnosed in a screening programme","volume":"43","author":"Mengual-Ballester","year":"2016","journal-title":"Cancer Epidemiol"},{"key":"2023102617252850000_73.736.e843.7","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.9412"},{"key":"2023102617252850000_73.736.e843.8","unstructured":"National Institute for Health and Care Excellence (2017) Quantitative faecal immunochemical tests to guide referral for colorectal cancer in primary care. DG30, https:\/\/www.nice.org.uk\/guidance\/dg30 (accessed 27 Sep 2023)."},{"issue":"10","key":"2023102617252850000_73.736.e843.9","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s10151-021-02466-z","article-title":"Quantitative FIT stratification is superior to NICE referral criteria NG12 in a high-risk colorectal cancer population","volume":"25","author":"Bailey","year":"2021","journal-title":"Tech Coloproctol"},{"key":"2023102617252850000_73.736.e843.10","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-321956"},{"key":"2023102617252850000_73.736.e843.11","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i19.2383"},{"issue":"2","key":"2023102617252850000_73.736.e843.12","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/bjs\/znab411","article-title":"Faecal immunochemical test to triage patients with possible colorectal cancer symptoms: meta-analysis","volume":"109","author":"Saw","year":"2022","journal-title":"Br J Surg"},{"key":"2023102617252850000_73.736.e843.13","doi-asserted-by":"crossref","unstructured":"Turvill JL Turnock D Cottingham D (2021) The Fast Track FIT study: diagnostic accuracy of faecal immunochemical test for haemoglobin in patients with suspected colorectal cancer. Br J Gen Pract, DOI: https:\/\/doi.org\/10.3399\/BJGP.2020.1098.","DOI":"10.3399\/BJGP.2020.1098"},{"issue":"5","key":"2023102617252850000_73.736.e843.14","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/s41416-021-01653-x","article-title":"Faecal immunochemical test for patients with \u2018high-risk\u2019 bowel symptoms: a large prospective cohort study and updated literature review","volume":"126","author":"Laszlo","year":"2022","journal-title":"Br J Cancer"},{"key":"2023102617252850000_73.736.e843.15","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15969"},{"key":"2023102617252850000_73.736.e843.16","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2019-000293"},{"key":"2023102617252850000_73.736.e843.17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.4093."},{"issue":"2","key":"2023102617252850000_73.736.e843.18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.surge.2020.03.002","article-title":"GP access to FIT increases the proportion of colorectal cancers detected on urgent pathways in symptomatic patients in Nottingham","volume":"19","author":"Bailey","year":"2021","journal-title":"Surgeon"},{"key":"2023102617252850000_73.736.e843.19","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-327985"},{"issue":"2","key":"2023102617252850000_73.736.e843.20","doi-asserted-by":"crossref","first-page":"zraa056","DOI":"10.1093\/bjsopen\/zraa056","article-title":"Faecal immunochemical testing and blood tests for prioritization of urgent colorectal cancer referrals in symptomatic patients: a 2-year evaluation","volume":"5","author":"Bailey","year":"2021","journal-title":"BJS Open"},{"key":"2023102617252850000_73.736.e843.21","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-320297"},{"key":"2023102617252850000_73.736.e843.22","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.socscimed.2015.04.010","article-title":"Decomposing socio-economic inequality in colorectal cancer screening uptake in England","volume":"134","author":"Solmi","year":"2015","journal-title":"Soc Sci Med"},{"key":"2023102617252850000_73.736.e843.23","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ypmed.2016.10.012","article-title":"The role of area-level deprivation and gender in participation in population-based faecal immunochemical test (FIT) colorectal cancer screening","volume":"93","author":"Clarke","year":"2016","journal-title":"Prev Med"},{"issue":"10","key":"2023102617252850000_73.736.e843.24","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/MCG.0000000000001132","article-title":"Individual and geospatial characteristics associated with use and nonuse of the fecal immunochemical test (FIT) for colorectal cancer screening in an urban minority population","volume":"53","author":"Ramai","year":"2019","journal-title":"J Clin Gastroenterol"},{"key":"2023102617252850000_73.736.e843.25","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyr008"},{"key":"2023102617252850000_73.736.e843.26","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.canep.2017.01.007","article-title":"The relationship between ethnicity, social deprivation and late presentation of colorectal cancer","volume":"47","author":"Askari","year":"2017","journal-title":"Cancer Epidemiol"},{"key":"2023102617252850000_73.736.e843.27","doi-asserted-by":"publisher","DOI":"10.3122\/jabfm.2019.02.180205"},{"issue":"1","key":"2023102617252850000_73.736.e843.28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/bjc.2016.399","article-title":"Adherence to colorectal cancer screening: four rounds of faecal immunochemical test-based screening","volume":"116","author":"van der Vlugt","year":"2017","journal-title":"Br J Cancer"},{"key":"2023102617252850000_73.736.e843.29","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605392"},{"key":"2023102617252850000_73.736.e843.30","doi-asserted-by":"publisher","DOI":"10.1093\/pubmed\/fdw147"},{"key":"2023102617252850000_73.736.e843.31","unstructured":"National Cancer Intelligence Network (NCIN), Cancer Research UK (2009) Cancer incidence and survival by major ethnic group, England, 2002\u20132006 (NCIN, London)."},{"key":"2023102617252850000_73.736.e843.32","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310691"},{"issue":"6","key":"2023102617252850000_73.736.e843.33","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/codi.14944","article-title":"Early clinical outcomes of a rapid colorectal cancer diagnosis pathway using faecal immunochemical testing in Nottingham","volume":"22","author":"Chapman","year":"2020","journal-title":"Colorectal Dis"},{"key":"2023102617252850000_73.736.e843.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2003.10.030"},{"key":"2023102617252850000_73.736.e843.35","doi-asserted-by":"publisher","DOI":"10.1258\/jms.2009.009080"},{"key":"2023102617252850000_73.736.e843.36","doi-asserted-by":"publisher","DOI":"10.1037\/0003-066X.58.1.5"},{"key":"2023102617252850000_73.736.e843.37","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.323.7320.1058"},{"key":"2023102617252850000_73.736.e843.38","doi-asserted-by":"publisher","DOI":"10.1136\/bmjqs-2021-014529"},{"key":"2023102617252850000_73.736.e843.39","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i5515"},{"issue":"8","key":"2023102617252850000_73.736.e843.40","doi-asserted-by":"crossref","first-page":"856","DOI":"10.4251\/wjgo.v13.i8.856","article-title":"Young-onset colorectal cancer: a review","volume":"13","author":"Done","year":"2021","journal-title":"World J Gastrointest Oncol"},{"key":"2023102617252850000_73.736.e843.41","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-319511"},{"key":"2023102617252850000_73.736.e843.42","doi-asserted-by":"crossref","unstructured":"von Wagner C Stoffel S Freeman M (2018) Attitudes towards faecal immunochemical testing in patients at increased risk of colorectal cancer: an online survey of GPs in England. Br J Gen Pract, DOI: https:\/\/doi.org\/10.3399\/bjgp18X699413.","DOI":"10.3399\/bjgp18X699413"},{"issue":"1","key":"2023102617252850000_73.736.e843.43","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s13063-016-1384-3","article-title":"A review of approaches to improve participation of culturally and linguistically diverse populations in clinical trials","volume":"17","author":"Hughson","year":"2016","journal-title":"Trials"},{"key":"2023102617252850000_73.736.e843.44","doi-asserted-by":"publisher","DOI":"10.5001\/omj.2020.40"},{"key":"2023102617252850000_73.736.e843.45","doi-asserted-by":"crossref","unstructured":"Georgiou Delisle T D\u2019Souza N Davies B (2022) Faecal immunochemical test for suspected colorectal cancer symptoms: patient survey of usability and acceptability. BJGP Open, DOI: https:\/\/doi.org\/10.3399\/BJGPO.2021.0102.","DOI":"10.3399\/BJGPO.2021.0102"}],"container-title":["British Journal of General Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3399\/BJGP.2023.0033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:29:51Z","timestamp":1698366591000},"score":1,"resource":{"primary":{"URL":"http:\/\/bjgp.org\/lookup\/doi\/10.3399\/BJGP.2023.0033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,23]]},"references-count":45,"journal-issue":{"issue":"736","published-online":{"date-parts":[[2023,10,26]]},"published-print":{"date-parts":[[2023,11]]}},"alternative-id":["10.3399\/BJGP.2023.0033"],"URL":"https:\/\/doi.org\/10.3399\/bjgp.2023.0033","relation":{},"ISSN":["0960-1643","1478-5242"],"issn-type":[{"value":"0960-1643","type":"print"},{"value":"1478-5242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,23]]}}}